Clinical trial
Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal…
NCT00447187 · Lux Biosciences, Inc., Industry · Terminated
Key facts
| NCT number | NCT00447187 |
|---|---|
| Title | Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk |
| Official title | A Multi-center, Placebo-Controlled, Randomized, Parallel Group, Dose-Ranging Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure Following Penetrating Keratoplasty With LX201 Implantation in Subjects Who Are at Increased… |
| Lead sponsor | Lux Biosciences, Inc., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Corneal Diseases, Cornea Transplant |
| Intervention type | Drug, Other |
| Interventions | LX201, Placebo |
| Enrollment | 368 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Nov 1, 2010 |
| First posted | Mar 14, 2007 |
| Last update posted | Oct 11, 2012 |
| Countries | Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: